HE4, Ovarian Cancer Monitoring
The percentage increase in HE4 values has been used as an aid in monitoring recurrence or progressive disease in patients with invasive epithelial ovarian cancer. Currently, there is no clinically accepted cut-off for use in monitoring cancer progression in epithelial ovarian cancer subjects with this assay. Serial testing for patient HE4 assay values should be used in conjunction with methods used for monitoring ovarian cancer.
Turnaround time: 5-7 business days
- This test cannot be collected in NY, NJ, MA, and RI. Contact us with questions.